Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ChronoScale Holdings CorpEKSO · Entity 4331 | Chief Operating Officer | July 13, 2018 | July 24, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ChronoScale Holdings Corp
Report date July 13, 2018 · Filed July 24, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.76 · Expires 2028-07-13 | Direct | 125,000 |
Reported balance
After 2018-07-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-07-13 · Grant · Acquired 125,000 · Balance 125,000 F1: The option becomes exercisable as to 25% of the total number of shares on the one year anniversary of the date of grant and thereafter vests in equal monthly installments for 36 months. |
Filing footnotes · ownership attribution and instrument terms
F1: The option becomes exercisable as to 25% of the total number of shares on the one year anniversary of the date of grant and thereafter vests in equal monthly installments for 36 months.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 13, 2018 Filed Jul 24, 2018 18:04 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | GrantEmployee Stock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001209191-18-043788 · doc4.xml · derivative · entry 1 DeLonzor Russ · CIK 0001694985 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2028-07-13 F1 · derivative.exercise_date: The option becomes exercisable as to 25% of the total number of shares on the one year anniversary of the date of grant and thereafter vests in equal monthly installments for 36 months. Read SEC document |
| May 10, 2018 Filed Jun 8, 2018 16:33 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | Exercise / conversionRestricted Stock Units · Derivative | 2,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-036700 · doc4.xml · derivative · entry 3 DeLonzor Russ · CIK 0001694985 · Vice Pres., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,437 Underlying: Common Stock · 2,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Ekso Bionics Holdings, Inc. common stock. F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on the one year anniversary of the date of grant. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on the one year anniversary of the date of grant. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| May 10, 2018 Filed Jun 8, 2018 16:33 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | Tax withholdingCommon Stock | 1,270 | $1.51 | $1,911.60 |
DisclosureSEC source: 0001209191-18-036700 · doc4.xml · nonDerivative · entry 2 DeLonzor Russ · CIK 0001694985 · Vice Pres., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,512 Read SEC document |
| May 10, 2018 Filed Jun 8, 2018 16:33 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | Exercise / conversionCommon Stock | 2,813 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-036700 · doc4.xml · nonDerivative · entry 1 DeLonzor Russ · CIK 0001694985 · Vice Pres., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,782 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Ekso Bionics Holdings, Inc. common stock. Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 17:13 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | Tax withholdingCommon Stock | 9,400 | $1.52 | $14,250.40 |
DisclosureSEC source: 0001209191-18-021771 · doc4.xml · nonDerivative · entry 2 DeLonzor Russ · CIK 0001694985 · Vice Pres., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,969 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.50 to $1.54, inclusive. The reporting person undertakes to provide to Ekso Bionics Holdings, Inc., any security holder of Ekso Bionics Holdings, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| March 22, 2018 Filed Mar 27, 2018 17:13 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | GrantCommon Stock | 24,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021771 · doc4.xml · nonDerivative · entry 1 DeLonzor Russ · CIK 0001694985 · Vice Pres., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,369 Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 19:25 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | GrantRestricted Stock Units · Derivative | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001578259-17-000016 · edgar.xml · derivative · entry 2 DeLonzor Russ · CIK 0001694985 · Vice Pres., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Ekso Bionics Holdings, Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on the one year anniversary of the date of grant. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on the one year anniversary of the date of grant. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 19:25 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | GrantEmployee Stock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0001578259-17-000016 · edgar.xml · derivative · entry 1 DeLonzor Russ · CIK 0001694985 · Vice Pres., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2027-04-20 F1 · derivative.exercise_date: The option becomes exercisable as to 25% of the total number of shares on the one year anniversary of the date of grant and thereafter vests in equal monthly installments for 36 months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.